Fulgent Genetics
360Dx Index Up 7 Percent in June, Rebounding From May Downturn
Of the 30 companies in the index, 24 firms saw their stock prices increase, while six firms' share prices decreased.Â
Fulgent Genetics Makes $19M Investment in Chinese JV, Takes Controlling Interest
Fulgent formed the joint venture in 2017 in order to establish a presence in China for its sequencing-based genetic testing services.
Fulgent Genetics Q1 Revenues Soar on SARS-CoV-2 Testing
The Temple City, California-based company raised its revenues and earnings guidance for 2021 on expected growth in its next-generation sequencing business.
Bucking Downward 2021 Trend, 360Dx Index Rebounds 4 Percent in April
Of the 30 companies in the index, 18 firms saw their stock prices increase, while 12 saw their share prices decline.
On a call with investors this week, the firm described massive revenue increases and discussed how it plans to sustain and deploy these gains.
Mar 4, 2021
Fulgent Genetics Q4 Revenues Skyrocket
Nov 24, 2020
BTIG Downgrades Fulgent Genetics from Buy to Neutral
Sep 15, 2020